Diagnostic Development, Approval, and Reimbursement begins by examining the big picture; the roles of U.S. government agencies and their regulatory authority over in vitro diagnostics (IVD) and laboratory-developed tests (LDT). The second section describes the regulatory requirements for Class I, II, and III diagnostic approval pathways. A review of the internationally recognized quality system regulations (QSR), focused on the design and manufacturing QSRs, closes out this section. Diagnostic Developemnt, Approval, and Reimbursement ends by explaining Medicare, Medicaid, hospital, and private payer reimbursement in terms of inpatient DRG codes and outpatient CPT codes.
Suggested Prerequisites
Diagnostics’ Role in Medicine Today
Certificate Requirements
- View the entire course
- Pass course exam with a 70 percent
Certificate Requirements
- View the entire course
- Pass course exam with a 70 percent
02 Section 1 Development and Regulation
Diagnostics: Regulation of New Clinical Tests
Summarizes the regulatory pathways for different categories of diagnostics and explains the differences in oversight from the Center of Medicare and M...More
03 Section 2: Diagnostic FDA Classification and Approval Pathways
Diagnostic Regulatory Pathways
Describes the regulatory burden of Class I, II, and III diagnostics and how to assess a diagnostic's class based on its risk profile. The FDA's 501(k)...More
04 Section 3: Reimbursement for Diagnostics
Certificate Requirements
- View the entire course
- Pass course exam with a 70 percent